Text Program to Help Rural Cancer Survivors Quit Smoking

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Recruiting Phase 3 Interventional Study
Cigarette Smoking-Related Carcinoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Prevention
Participants needed
600 (estimated)
Sponsor
Alliance for Clinical Trials in Oncology · Other
Who this trial is looking for

This trial is looking for rural cancer survivors who smoke and want to quit. Participants will receive support through a text-based program designed to help reduce smoking.

Are You a Good Fit for This Trial?
Must not be taking Nicotine replacement therapyBupropionVarenicline

You may be able to join if

  • I have been diagnosed with cancer within the past 10 years.
  • I smoke at least 5 cigarettes a day.
  • I live in a rural area.
  • I am interested in joining a program to stop smoking.
  • I can speak and read English or Spanish.
  • I am at least 18 years old.
  • I have a smartphone with texting ability.
  • I am willing to provide a urine sample.

You may not be able to join if

  • I am currently receiving hospice care.
  • I only vape and do not smoke cigarettes.
  • I am using smoking cessation medications.
  • I am currently in another smoking cessation clinical trial.
  • I have impaired decision-making capacity.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This phase III trial compares the effect of text-based cessation intervention to a manual in helping rural cancer patients who smoke, quit. Text-based scheduled gradual reduction may reduce the frequency of cigarette use to zero and may be effective in quitting smoking.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Have a cancer diagnosis within the past 10 years \* Note: Patients with ductal carcinoma in situ (DCIS) are eligible and patients currently receiving curative treatment are eligible * Not currently on hospice * Currently smokes \>= 5 cigarettes daily \* Note: Participant…
Contacts

Devon Noonan, PhD, MPH, FNP-BC

919-613-9130

devon.noonan@duke.edu

CONTACT